EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Microbiome Guided Precision Pharmacology in Pregnancy: Organ Crosstalk, Maternal–Fetal Drug Disposition, and PBPK ‐Informed Dosing

Nila Ganamurali iD, Mohanapriya Devarajan, Sarvesh Sabarathinam iD

Comprehensive Physiology · 2026-04 · 16 (2)

DOI: 10.1002/cph4.70138 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Comprehensive Physiology, online erschienen am 27.03.2026. Verfasst von Nila Ganamurali und 2 weiteren Autor:innen. Beteiligte Einrichtung: Helix Research Lab, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chenna…. Die Arbeit nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug therapy during pregnancy poses unique challenges, requiring a balance between maternal benefit and fetal safety. Profound physiological changes, including altered plasma volume, protein binding, hepatic metabolism, renal clearance, and placental transfer, transform pregnancy pharmacology into a dynamic process. Classical concepts such as initiation, loading, maintenance, tapering, and therapeutic monitoring remain fundamental but demand gestation‐specific adaptations. This overview integrates fundamental pharmacological concepts with clinical practices tailored for pregnancy, such as personalized dosing, therapeutic monitoring, and structured tapering. Recent studies further underscore the role of the maternal gut microbiome in shaping drug metabolism, absorption, and overall exposure. Variations in how individuals respond to medication during pregnancy may stem from microbial enzymes and metabolites that interact with the body's pharmacokinetic processes. By merging microbiome data with physiologically based pharmacokinetic modeling and pharmacometric tools, clinicians can enhance drug disposition forecasts and refine precision dosing strategies in obstetric care.

Schlagwörter

Stichwörter der Autor:innen

good health and well‐beinggut microbiomematernal–fetal drug dispositionphysiologically based pharmacokinetics (PBPK)precision dosingtherapeutic drug monitoring (TDM)

Autor:innen und Institutionen

  • Helix Research Lab, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India.
  • Department of Gynaecologic Oncology, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India.

ORCID-Profile: Nila Ganamurali, Sarvesh Sabarathinam

Zitieren

APA

Ganamurali, N., Devarajan, M., & Sabarathinam, S. (2026). Microbiome Guided Precision Pharmacology in Pregnancy: Organ Crosstalk, Maternal–Fetal Drug Disposition, and PBPK ‐Informed Dosing. Comprehensive Physiology, 16(2). https://doi.org/10.1002/cph4.70138

Vancouver

Ganamurali N, Devarajan M, Sabarathinam S. Microbiome Guided Precision Pharmacology in Pregnancy: Organ Crosstalk, Maternal–Fetal Drug Disposition, and PBPK ‐Informed Dosing. Comprehensive Physiology. 2026;16(2). doi:10.1002/cph4.70138

BibTeX
@article{Ganamurali2026,
  author = {Ganamurali, Nila and Devarajan, Mohanapriya and Sabarathinam, Sarvesh},
  title = {Microbiome Guided Precision Pharmacology in Pregnancy: Organ Crosstalk, Maternal–Fetal Drug Disposition, and PBPK ‐Informed Dosing},
  journal = {Comprehensive Physiology},
  year = {2026},
  volume = {16},
  number = {2},
  doi = {10.1002/cph4.70138}
}
Kostenlos starten →